Vasudev Kantae

Vasudev Kantae, PhD, is currently an Associate Director at AstraZeneca, where they lead bioanalytical strategy and oversee mass spectrometry-based quantitative analysis in early drug discovery. With over 12 years of experience in the field, Vasudev has contributed to the development of innovative workflows that support oncology therapeutics. Previously, they served as a Postdoctoral Researcher at Leiden University, focusing on the molecular mechanisms associated with neurodegenerative diseases, and have held various roles at AstraZeneca since 2021. Vasudev holds a PhD in Analytical Biochemistry from Leiden University and a Master's degree in Biotechnology from the University of Helsinki.